News

The CDC's Advisory Committee on Immunization Practices recommended the removal of the preservative thimerosal in seasonal influenza vaccines at their meeting.
The University of Minnesota is stepping up efforts to identify biological threats that could trigger an epidemic, launching ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Arcturus has made progress in cost-cutting and focusing on CF and OTC deficiency. Click here to find out the factors that ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
"This is a very clear effort to shine a light on this anti-vaccine trope: that thimerosal is somehow dangerous.” ...
Today, a new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of vaccination ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
The preservative is in a small share of flu shots and has been studied for decades. Experts say it’s safe — despite Kennedy’s long opposition.
Moderna shares rose on the increased effectiveness of its flu vaccine in late-stage trials, bring the biotech company closer ...